Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion type Assertion NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_head.
- NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion description "[ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6.3%) and no K-RAS mutations, intermediate features regarding expressions of p53 (37.5%) and p16 (25%), and endometrioid adenocarcinoma-like features regarding losses of PTEN (81.3%), ARID1A (25%) and mismatch-repair protein (68.8%), expression of microsatellite instability-high (25%), HER2/neu (12.5%), and PIK3CA mutations (18.8%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_provenance.
- NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion evidence source_evidence_literature NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_provenance.
- NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion SIO_000772 25473756 NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_provenance.
- NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion wasDerivedFrom befree-2016 NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_provenance.
- NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_assertion wasGeneratedBy ECO_0000203 NP1244696.RAVoDef4dEcrAStvGVvs5q8d1z5jcL-z547amV45sEQG0130_provenance.